HOW DO YOU GET LUPUS?

EULAR 2011 – Vidofludimus Superior To Cyclophosphamide And MMF In An Experimental Systemic Lupus Erythematosus Model

—

by

Lupus Site Administrator
in

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus – its lead small-molecule drug candidate against autoimmune diseases – in systemic lupus erythematosus (SLE) at EULAR 2011, Europe’s largest scientific conference on rheumatic diseases, i…

Related posts:

  1. American College Of Rheumatology 2011 Annual Meeting: Presentations By NYU Langone Experts
  2. MMF Found Superior to Azathioprine for Lupus Nephritis Maintenance
  3. Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview.
  4. A proposed model for physiologic and pathologic regulation in systemic lupus erythematosus.